Today’s top gainers include the company Mylan N.V. (NASDAQ:MYL) which is in the industry Drugs – Generic, gaining -0.51% today. In the last week its performance is 0.33%, and 26.13% for the past quarter. Currently, Mylan N.V., MYL has a target price of 58.06, so today’s gain of -0.51% is a significant step towards its target price. The GAP today is therefore -0.64%.
Mylan N.V. (NASDAQ:MYL), has a market cap of 23732.49, and is based in USA. Insider ownership is at 0.70%, and institutional ownership is 70.80%.
At the current price of 48.46, it has a dividend yield of *TBA, and its target price is 58.06. This is with a profit margin of 8.30%, and total debt/equity of 0.73. Mylan N.V. (NASDAQ:MYL) has a P/E of 31.14, as well as a forward P/E of 8.36.
With a current EPS of 1.56, and a forecasted EPS growth for next year at 17.70%,Mylan N.V. (NASDAQ:MYL) has had a EPS growth for the past five years at 20.20%. For the next five years EPS growth is projected to be 13.96%.
Performance for the year is -12.01%. Since its IPO date on 12/18/1987, the total performance to date is -9.91%.
Volume today for Mylan N.V. (NASDAQ:MYL), is 3623229, while its average volume is 4568.14. Whilst the total gain today was -0.51%, it did have a day high of -3.85%.
Volatility for this week has been at 2.66%, and 2.52% for the month. The 52-week low for Mylan N.V., MYL has been 28.92%, while the 52-week-high has reached -14.74%.
Looking at its return of investments, which is 8.20%, and its return on assets is 3.60%. Mylan N.V. (NASDAQ:MYL) has an operating margin of 14.60%. With a sales growth of 17.10% quarter over quarter. Bearing in mind that Mylan N.V., MYL is in the sector Healthcare, its long-term debt/equity is 0.62, and has a current ratio of 1.7 and 1.1 for quick ratio.
So what is the value of Mylan N.V.? Well its PEG is 2.23, and the P/S is 2.43, along with a P/B of 2.32. Meanwhile it has a p/cash of 19.79.